In an administrative switch to bring their communications with pharmaceutical and medical device companies up to date, Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has begun accepting drug and device registration and approval application inquiries by email. Applicants who wish can still route their inquiries by fax.
